Mosquito-Borne Diseases
Mosquito-Borne Diseases
Explore linked clinical trials. Standard reference: MESH:M000677018209 results · Page 1 of 9
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Positron Emission Tomography and Organ-Specific Changes in Participants Co-Enrolled in NIH Studies of Plasmodium Vivax Controlled Human Malaria Infection | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not applicable | 2026-10-09 | NCT07859800 | |
| Southeast Asia Dose Optimization of Tafenoquine | Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Plasmodium vivax malaria, Recurrence, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 4 | 2026-10-09 | NCT04704999 | |
| Laboratory Evaluation of Pregnancy Malaria Vaccine Candidates/In-vitro Testing of Pregnancy Malaria Vaccine Candidates | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT02471378 | |
| Host and Parasite Factors That Influence Susceptibility to Malaria Infection and Disease During Pregnancy and Early Childhood in Ouelessebougou and Bamako, Mali | Body Temperature Changes, Fever, Infections, Mosquito-Borne Diseases, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-08 | NCT01168271 | |
| Better Options for Lymphatic Filariasis Treatment | Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, Nematoda infectious disease, Rhabditida infectious disease, Secernentea Infections, Skin and Connective Tissue Diseases, Spirurida Infections, filarial elephantiasis, filariasis, helminthiasis, lymphatic system disorder, lymphedema, mite infestation, parasitic ectoparasitic infectious disease, parasitic infectious disease, parasitic skin disorder, scabies, skin disorder, skin disorder caused by infection, strongyloidiasis, vector-borne disease | Recruiting | Phase 3 | 2026-10-07 | NCT07159373 | |
| First-in-Human Dose-escalation of GSK4425689A: Safety, Tolerability, and PK in Healthy Adults | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-10-05 | NCT07646353 | |
| RVF and Other Emerging Infectious Diseases in East and Central Africa | Bunyaviridae infectious disease, Communicable Diseases, Emerging, Digestive System Diseases, Disease Attributes, Infections, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Rift valley fever, arbovirus infection, hepatitis, hepatitis, non-human animal, hepatitis, viral, animal, infectious disease, liver disorder, non-human animal disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-10-05 | NCT05139524 | |
| Collection of Human Biospecimens for Basic and Clinical Research Into Globin Variants | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Infections, Mosquito-Borne Diseases, anemia, beta thalassemia, familial hemolytic anemia, hematologic disorder, hemolytic anemia, hereditary disease, inherited hemoglobinopathy, malaria, parasitic infectious disease, protozoa infectious disease, sickle cell disease, thalassemia, vector-borne disease | Recruiting | Not stated | 2026-10-02 | NCT03937817 | |
| Evaluation, Treatment and Monitoring of Patients With a Known or Suspected Parasitic Infection | Infections, Mosquito-Borne Diseases, Trematode Infections, helminthiasis, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Not stated | 2026-10-02 | NCT00001645 | |
| An Interventional Study to Compare the Efficacy and Safety of Tafenoquine (TQ) and Primaquine (PQ) When Either Are Taken Together With Chloroquine (CQ) for the Treatment of P. Vivax Malaria in Indian Participants Aged 2 Years and Older | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 3 | 2026-10-01 | NCT06666491 | |
| A Safety and Immunogenicity Study of CHIKV VLP Vaccine in Children. | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Active, not recruiting | Phase 3 | 2026-09-30 | NCT07003984 | |
| Evaluation of IXCHIQ® Vaccine Immunogenicity | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Not yet recruiting | Phase 2 | 2026-09-29 | NCT07846293 | |
| Infant Malaria Vaccine Schedule Optimization | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Phase 2 | 2026-09-29 | NCT06879327 | |
| Real-world Effectiveness, Safety & Immunogenicity of Chikungunya Vaccination: Ambispective Study in Reunion & French Guiana | Alphavirus infectious disease, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Togaviridae infectious disease, arbovirus infection, chikungunya, vector-borne disease, viral infectious disease | Recruiting | Phase 4 | 2026-09-28 | NCT06928753 | |
| Adaptive Dengue Antiviral Platform Trial | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 2 | 2026-09-28 | NCT06551844 | |
| Ethiopian Antimalarial Therapeutic Efficacy Study 2026 | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Not stated | 2026-09-25 | NCT07840898 | |
| Safety and Immunogenicity of the Recombinant Malaria Vaccines in Healthy Adults Aged 18-50 Years | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 1 | 2026-09-25 | NCT07831226 | |
| Phase 1 Challenge Study Using rDEN2delta30-7169 to Evaluate Host-Pathogen Interactions in Primary, Homotypic, and Heterotypic Dengue Virus Infection | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Phase 1 | 2026-09-25 | NCT07706686 | |
| Induced Blood-Stage Malaria in Healthy Malaria-Naive Adults to Assess the Safety and Infectivity of Plasmodium Vivax Challenge Agent and Evaluate Transmission in Mosquito Feeding Assays | Infections, Inflammation, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Sepsis, Systemic Inflammatory Response Syndrome, malaria, parasitemia, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-09-25 | NCT06607003 | |
| Safety, Tolerability, Pharmacokinetics, and Mosquitocidal Activity of Lotilaner in Healthy Participants in Mali. | Infections, Mosquito-Borne Diseases, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Recruiting | Phase 1 | 2026-09-24 | NCT07758985 | |
| Immune Responses to Dengue and Sepsis | Flaviviridae infectious disease, Flavivirus Infections, Infections, Inflammation, Mosquito-Borne Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, RNA Virus Infections, Sepsis, Systemic Inflammatory Response Syndrome, arbovirus infection, dengue disease, influenza, respiratory system disorder, respiratory tract infectious disorder, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Recruiting | Not stated | 2026-09-23 | NCT07040202 | |
| Tafenoquine Drug Levels in Small Children | Infections, Mosquito-Borne Diseases, Plasmodium vivax malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Not yet recruiting | Phase 2 | 2026-09-22 | NCT07835321 | |
| IGHID 12334 - After the Flood: Optimal Strategies to Prevent Malaria Epidemics Caused by Severe Flooding | Infections, Mosquito-Borne Diseases, Plasmodium falciparum malaria, malaria, parasitic infectious disease, protozoa infectious disease, vector-borne disease | Active, not recruiting | Not applicable | 2026-09-22 | NCT06870344 | |
| A Study of Dengue Tetravalent Vaccine (TDV) in Adults (Age 45 to 60 and >60 to 79 Years) | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, arbovirus infection, dengue disease, vector-borne disease, viral hemorrhagic fever, viral infectious disease | Active, not recruiting | Phase 3 | 2026-09-22 | NCT06579755 | |
| Screening for LID Clinical Studies Unit Healthy Volunteer Protocols | Flaviviridae infectious disease, Flavivirus Infections, Infections, Mosquito-Borne Diseases, RNA Virus Infections, Zika virus infectious disease, arbovirus infection, influenza, respiratory system disorder, respiratory tract infectious disorder, vector-borne disease, viral infectious disease | Recruiting | Not stated | 2026-09-22 | NCT01386424 |